Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases

NCT01004172 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Breast Cancer
Progressive Breast Cancer

Interventions

DRUG: carboplatin
DRUG: bevacizumab
DRUG: herceptin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]